Praxis Precision Medicines, Inc. PRAX Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five?
- Praxis Precision Medicines, Inc. (PRAX) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five of $660.94M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five changed year-over-year?
- Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five increased by 358.9% year-over-year, from $144.03M to $660.94M.